Proteak Uno, S.A.B. de C.V. Logo

Proteak Uno, S.A.B. de C.V.

TEAKCPO.MX

(1.0)
Stock Price

1 MXN

-9.85% ROA

-18.96% ROE

-1.29x PER

Market Cap.

2.127.752.909 MXN

72.61% DER

0% Yield

-39.41% NPM

Proteak Uno, S.A.B. de C.V. Stock Analysis

Proteak Uno, S.A.B. de C.V. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Proteak Uno, S.A.B. de C.V. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.26x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a reasonable amount of debt compared to its ownership (72%), suggesting a balanced financial position and a moderate level of risk.

3 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

4 ROE

Negative ROE (-14.04%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-7.72%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-2) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Proteak Uno, S.A.B. de C.V. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Proteak Uno, S.A.B. de C.V. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Proteak Uno, S.A.B. de C.V. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Proteak Uno, S.A.B. de C.V. Revenue
Year Revenue Growth
2010 30.133.000
2011 19.501.514 -54.52%
2012 85.299.815 77.14%
2013 153.720.000 44.51%
2014 418.862.000 63.3%
2015 237.381.000 -76.45%
2016 533.389.000 55.5%
2017 895.271.000 40.42%
2018 1.195.562.000 25.12%
2019 1.333.462.000 10.34%
2020 1.165.668.000 -14.39%
2021 1.938.424.000 39.87%
2022 1.919.690.000 -0.98%
2023 1.342.120.000 -43.03%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Proteak Uno, S.A.B. de C.V. Research and Development Expenses
Year Research and Development Expenses Growth
2010 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Proteak Uno, S.A.B. de C.V. General and Administrative Expenses
Year General and Administrative Expenses Growth
2010 0
2011 0 0%
2012 -18.892.743 100%
2013 58.408.000 132.35%
2014 52.465.000 -11.33%
2015 49.725.000 -5.51%
2016 123.154.000 59.62%
2017 280.693.000 56.13%
2018 234.018.000 -19.95%
2019 237.240.000 1.36%
2020 261.435.000 9.25%
2021 239.336.000 -9.23%
2022 213.518.000 -12.09%
2023 113.884.000 -87.49%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Proteak Uno, S.A.B. de C.V. EBITDA
Year EBITDA Growth
2010 -33.033.992
2011 -23.095.648 -43.03%
2012 47.609.781 148.51%
2013 -166.468.000 128.6%
2014 160.491.000 203.72%
2015 113.290.000 -41.66%
2016 -96.698.000 217.16%
2017 119.088.000 181.2%
2018 131.945.000 9.74%
2019 220.928.000 40.28%
2020 -42.237.000 623.07%
2021 398.190.000 110.61%
2022 -79.013.000 603.96%
2023 -258.552.000 69.44%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Proteak Uno, S.A.B. de C.V. Gross Profit
Year Gross Profit Growth
2010 13.404.000
2011 -4.796.832 379.43%
2012 85.600.763 105.6%
2013 -90.472.000 194.62%
2014 255.087.000 135.47%
2015 186.577.000 -36.72%
2016 110.513.000 -68.83%
2017 191.342.000 42.24%
2018 224.336.000 14.71%
2019 245.794.000 8.73%
2020 257.873.000 4.68%
2021 590.593.000 56.34%
2022 -2.819.000 21050.44%
2023 45.124.000 106.25%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Proteak Uno, S.A.B. de C.V. Net Profit
Year Net Profit Growth
2010 -13.547.000
2011 -30.166.475 55.09%
2012 38.241.278 178.88%
2013 -17.742.000 315.54%
2014 83.521.000 121.24%
2015 60.987.000 -36.95%
2016 -372.209.000 116.39%
2017 -136.968.000 -171.75%
2018 -155.882.000 12.13%
2019 -67.395.000 -131.3%
2020 -218.897.000 69.21%
2021 220.324.000 199.35%
2022 -305.767.000 172.06%
2023 -513.680.000 40.48%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Proteak Uno, S.A.B. de C.V. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2010 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -1 100%
2017 0 0%
2018 -1 0%
2019 0 0%
2020 -1 0%
2021 1 0%
2022 -1 0%
2023 -1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Proteak Uno, S.A.B. de C.V. Free Cashflow
Year Free Cashflow Growth
2010 -205.504.193
2011 -607.802.520 66.19%
2012 -145.014.246 -319.13%
2013 -108.555.000 -33.59%
2014 -639.408.000 83.02%
2015 -1.441.163.000 55.63%
2016 -312.288.000 -361.49%
2017 -210.262.000 -48.52%
2018 -139.317.000 -50.92%
2019 140.508.000 199.15%
2020 57.442.000 -144.61%
2021 117.946.000 51.3%
2022 26.426.000 -346.33%
2023 19.419.000 -36.08%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Proteak Uno, S.A.B. de C.V. Operating Cashflow
Year Operating Cashflow Growth
2010 -112.557.066
2011 -376.169.621 70.08%
2012 -95.628.886 -293.36%
2013 -108.555.000 11.91%
2014 -279.698.000 61.19%
2015 -11.665.000 -2297.75%
2016 -191.447.000 93.91%
2017 -167.943.000 -14%
2018 -112.004.000 -49.94%
2019 152.523.000 173.43%
2020 66.089.000 -130.78%
2021 154.266.000 57.16%
2022 99.710.000 -54.71%
2023 31.282.000 -218.75%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Proteak Uno, S.A.B. de C.V. Capital Expenditure
Year Capital Expenditure Growth
2010 92.947.127
2011 231.632.899 59.87%
2012 49.385.360 -369.03%
2013 0 0%
2014 359.710.000 100%
2015 1.429.498.000 74.84%
2016 120.841.000 -1082.96%
2017 42.319.000 -185.55%
2018 27.313.000 -54.94%
2019 12.015.000 -127.32%
2020 8.647.000 -38.95%
2021 36.320.000 76.19%
2022 73.284.000 50.44%
2023 11.863.000 -517.75%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Proteak Uno, S.A.B. de C.V. Equity
Year Equity Growth
2010 970.041.000
2011 1.069.398.186 9.29%
2012 1.159.084.374 7.74%
2013 1.925.209.000 39.79%
2014 2.333.948.000 17.51%
2015 2.986.855.000 21.86%
2016 2.959.799.000 -0.91%
2017 3.035.297.000 2.49%
2018 3.231.910.000 6.08%
2019 3.254.766.000 0.7%
2020 3.440.032.000 5.39%
2021 3.820.076.000 9.95%
2022 3.294.523.000 -15.95%
2023 3.001.344.000 -9.77%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Proteak Uno, S.A.B. de C.V. Assets
Year Assets Growth
2010 1.025.182.000
2011 1.153.216.702 11.1%
2012 1.373.914.914 16.06%
2013 2.372.378.000 42.09%
2014 3.093.469.000 23.31%
2015 5.235.202.000 40.91%
2016 6.121.579.000 14.48%
2017 6.343.270.000 3.49%
2018 6.293.879.000 -0.78%
2019 6.161.065.000 -2.16%
2020 6.398.197.000 3.71%
2021 6.849.579.000 6.59%
2022 6.404.444.000 -6.95%
2023 5.818.654.000 -10.07%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Proteak Uno, S.A.B. de C.V. Liabilities
Year Liabilities Growth
2010 55.141.000
2011 83.818.516 34.21%
2012 214.830.540 60.98%
2013 447.169.000 51.96%
2014 655.410.000 31.77%
2015 2.100.664.000 68.8%
2016 3.045.718.000 31.03%
2017 3.163.101.000 3.71%
2018 3.061.969.000 -3.3%
2019 2.906.299.000 -5.36%
2020 2.958.165.000 1.75%
2021 3.029.503.000 2.35%
2022 3.109.921.000 2.59%
2023 2.817.310.000 -10.39%

Proteak Uno, S.A.B. de C.V. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
3.74
Net Income per Share
-1.47
Price to Earning Ratio
-1.29x
Price To Sales Ratio
1.46x
POCF Ratio
-441.69
PFCF Ratio
-38.3
Price to Book Ratio
0.26
EV to Sales
2.86
EV Over EBITDA
-9.85
EV to Operating CashFlow
-2480.83
EV to FreeCashFlow
-74.74
Earnings Yield
-0.78
FreeCashFlow Yield
-0.03
Market Cap
2 Bil.
Enterprise Value
4 Bil.
Graham Number
15.67
Graham NetNet
-6.39

Income Statement Metrics

Net Income per Share
-1.47
Income Quality
0
ROE
-0.19
Return On Assets
-0.1
Return On Capital Employed
-0.14
Net Income per EBT
0.79
EBT Per Ebit
1.03
Ebit per Revenue
-0.48
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0.12
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.32
Operating Profit Margin
-0.48
Pretax Profit Margin
-0.5
Net Profit Margin
-0.39

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0.14
Capex to Operating CashFlow
32.19
Capex to Revenue
-0.04
Capex to Depreciation
-0.37
Return on Invested Capital
-0.11
Return on Tangible Assets
-0.1
Days Sales Outstanding
0
Days Payables Outstanding
36.96
Days of Inventory on Hand
99.93
Receivables Turnover
0
Payables Turnover
9.88
Inventory Turnover
3.65
Capex per Share
-0.14

Balance Sheet

Cash per Share
0,18
Book Value per Share
7,41
Tangible Book Value per Share
7.71
Shareholders Equity per Share
7.41
Interest Debt per Share
5.79
Debt to Equity
0.73
Debt to Assets
0.36
Net Debt to EBITDA
-4.8
Current Ratio
1.13
Tangible Asset Value
3 Bil.
Net Current Asset Value
-2 Bil.
Invested Capital
0.73
Working Capital
0 Bil.
Intangibles to Total Assets
0
Average Receivables
0 Bil.
Average Payables
0 Bil.
Average Inventory
550719500
Debt to Market Cap
0.98

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Proteak Uno, S.A.B. de C.V. Dividends
Year Dividends Growth

Proteak Uno, S.A.B. de C.V. Profile

About Proteak Uno, S.A.B. de C.V.

CEO
Mr. Cesar Arturo Velez Ponguta
Employee
798
Address

,

Proteak Uno, S.A.B. de C.V. Executives & BODs

Proteak Uno, S.A.B. de C.V. Executives & BODs
# Name Age
1 Mr. Cesar Arturo Velez Ponguta
Managing Director
70
2 Mr. Ivan Ahedo Gaudry
Marketing Director
70
3 Mr. Hector Eduardo Bonilla Castaneda
Founder
70
4 Ms. Mariana Rojo Granados
Director of Administration & Finance
70
5 Mr. Cesar Alejandro Rodriguez Bejarano
Sales Director
70
6 Ms. Ofelia Rendon Rodriguez
Human Development Director
70
7 Ms. Cinthia Paulina Villasenor Islas
Legal & Compliance Director
70

Proteak Uno, S.A.B. de C.V. Competitors